Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 6
1981 2
1982 3
1983 7
1984 7
1985 7
1986 7
1987 7
1988 7
1989 10
1990 14
1991 4
1992 11
1993 9
1994 6
1995 6
1996 6
1997 6
1998 6
1999 6
2000 4
2001 4
2002 8
2003 8
2004 5
2005 6
2006 2
2007 9
2008 7
2009 8
2010 1
2011 6
2012 4
2013 7
2014 9
2015 7
2016 9
2017 6
2018 9
2019 12
2020 16
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

288 results
Results by year
Filters applied: . Clear all
Page 1
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Kostine M, Finckh A, Bingham CO, Visser K, Leipe J, Schulze-Koops H, Choy EH, Benesova K, Radstake TRDJ, Cope AP, Lambotte O, Gottenberg JE, Allenbach Y, Visser M, Rusthoven C, Thomasen L, Jamal S, Marabelle A, Larkin J, Haanen JBAG, Calabrese LH, Mariette X, Schaeverbeke T. Kostine M, et al. Among authors: calabrese lh. Ann Rheum Dis. 2021 Jan;80(1):36-48. doi: 10.1136/annrheumdis-2020-217139. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327425 Free PMC article.
Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.
Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL. Wilson MR, et al. Among authors: calabrese lh. JAMA Neurol. 2018 Aug 1;75(8):947-955. doi: 10.1001/jamaneurol.2018.0463. JAMA Neurol. 2018. PMID: 29710329 Free PMC article.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
Winthrop KL, Mariette X, Silva JT, Benamu E, Calabrese LH, Dumusc A, Smolen JS, Aguado JM, Fernández-Ruiz M. Winthrop KL, et al. Among authors: calabrese lh. Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S21-S40. doi: 10.1016/j.cmi.2018.02.002. Epub 2018 Feb 12. Clin Microbiol Infect. 2018. PMID: 29447987 Free article. Review.
Viral arthritis.
Calabrese LH, Naides SJ. Calabrese LH, et al. Infect Dis Clin North Am. 2005 Dec;19(4):963-80, x. doi: 10.1016/j.idc.2005.09.002. Infect Dis Clin North Am. 2005. PMID: 16297742 Review.
Is France Once Again Looking for a Scapegoat?
Lederman MM, Flier JS, Hale P, Haase AT, Powderly W, Reiss P, Silvestri G, Sekaly RP, Paiardini M, Weissman D, Kuritzkes DR, Calabrese LH, Agre P, Reyes-Teran G, Landay AL, Lewin S, Richman DD, Volberding P, Hunt PW, Schechter M. Lederman MM, et al. Among authors: calabrese lh. Pathog Immun. 2021 Dec 29;6(2):149-152. doi: 10.20411/pai.v6i2.490. eCollection 2021. Pathog Immun. 2021. PMID: 35097250 Free PMC article.
Drug-induced vasculitis.
Calabrese LH, Duna GF. Calabrese LH, et al. Curr Opin Rheumatol. 1996 Jan;8(1):34-40. doi: 10.1097/00002281-199601000-00006. Curr Opin Rheumatol. 1996. PMID: 8867537 Review.
Type I interferon, anti-interferon antibodies, and COVID-19.
Calabrese LH, Winthrop K, Strand V, Yazdany J, Walter JE. Calabrese LH, et al. Lancet Rheumatol. 2021 Apr;3(4):e246-e247. doi: 10.1016/S2665-9913(21)00034-5. Epub 2021 Feb 1. Lancet Rheumatol. 2021. PMID: 33655222 Free PMC article. No abstract available.
288 results